What is the Purpose of this Study?
The purpose of this clinical trial is to evaluate the safety and effectiveness of the AltaValve System in treatment of moderate-to-severe and severe mitral regurgitation in target patient population.
Eligibility
- * Age ≥ 18 years.
- * Symptomatic New York Heart Association (NYHA) class II-IV.
- * Moderate-to-severe or severe MR (3+) despite optimal guideline-directed medical therapy (GDMT) as determined by an independent Echo Core Lab.
- * Unsuitable for surgery and Transcatheter Edge-toEdge Repair (TEER) as determined by the local site Heart Team.
Where can I participate?
Cedars Sinai Medical Center
More about this Clinical Trial
What is the full name of this clinical trial?
AltaValve Pivotal Trial Protocol